NIH scientists find a potential new avenue for cancer therapies
- Details
- Category: Research
Recent findings in mice suggest that blocking the production of small molecules produced in the body, known as epoxyeicosatrienoic acids (EETs), may represent a novel strategy for treating cancer by eliminating the blood vessels that feed cancer tumors.
A gene that protects against colorectal cancers
- Details
- Category: Research
The research team at Lyon has developed an animal model carrying a mutation of the DCC gene. Mice carrying the mutation develop tumours, because this gene can no longer induce the death of the cancer cells. This discovery could lead to the development of a new targeted cancer treatment that aims to reactivate the dying of cancer cells.
New light on medicinal benefits of plants
- Details
- Category: Research
Scientists are about to make publicly available all the data they have so far on the genetic blueprint of medicinal plants and what beneficial properties are encoded by the genes identified.
Blood test might predict how well a depressed patient responds to antidepressants
- Details
- Category: Research
Loyola University Medical Center researchers are reporting what could become the first reliable method to predict whether an antidepressant will work on a depressed patient. The method would involve a blood test for a protein called vascular endothelial growth factor (VEGF).
Commercial or communal: Why is outsourcing taboo for churches and pharmaceutical companies?
- Details
- Category: Research
Consumers hold churches and pharmaceutical companies to different moral standards than other organizations, according to a new study in the Journal of Consumer Research.
Scientists discover new way to target cancer
- Details
- Category: Research
Scientists have discovered a new way to target cancer through manipulating a master switch responsible for cancer cell growth. The findings, published in the journal Cancer Cell, reveal how cancer cells grow faster by producing their own blood vessels.
Mayo Clinic researchers find drug duo kills chemotherapy-resistant ovarian cancer cells
- Details
- Category: Research
The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida.
More Pharma News ...
- Plasma-based treatment goes viral
- New Potential Personalized Medicine Platform
- Breakthrough in the battle against malaria
- Researchers engineer blood stem cells to fight melanoma
- Researchers discover clues to developing more effective antipsychotic drugs
- One adult in ten will have diabetes by 2030
- Vaccine for metastatic breast, ovarian cancer shows promise